Bioceres Crop Solutions (BIOX) EBITDA (2016 - 2026)

Bioceres Crop Solutions has disclosed EBITDA across 11 years of filings, most recently posting -$600000.0 for Q1 2026.

• In Q1 2026, EBITDA fell 106.59% year-over-year to -$600000.0; the TTM figure through Mar 2026 stood at -$770061.0 (down 100.91% YoY), while the FY2025 annual figure was -$2.2 million, down 104.88% from the prior year.
• EBITDA came in at -$600000.0 for Q1 2026 at Bioceres Crop Solutions, down from $7.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $85.2 million in Q3 2023 to a low of -$15.2 million in Q2 2022.
• Average EBITDA over 5 years is $17.5 million, with a median of $10.5 million recorded in 2023.
• Year-over-year, EBITDA sank 183.11% in 2022 and jumped 2942.86% in 2023.
• Over 5 years, EBITDA stood at $2.2 million in 2022, then surged by 373.19% to $10.5 million in 2023, then surged by 36.8% to $14.4 million in 2024, then tumbled by 47.63% to $7.5 million in 2025, then slumped by 107.98% to -$600000.0 in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$600000.0 in Q1 2026, $7.5 million in Q4 2025, and $7.2 million in Q3 2025.